What is Savara's other commercial liabilities?

Savara (SVRA) reported other commercial liabilities of $11.04M in Q1 2026.

How has Savara's other commercial liabilities changed year-over-year?

Savara's other commercial liabilities increased by 74.2% year-over-year, from $6.34M to $11.04M.

What is the long-term trend for Savara's other commercial liabilities?

Over 5 years (2020 to 2025), Savara's other commercial liabilities has grown at a 21.3% compound annual growth rate (CAGR), from $5.58M to $14.64M.

Savara SVRA Other Commercial Liabilities

Other Commercial Liabilities at other companies

XER

Xeris Biopharma Holdings, Inc.XERS

——

ANI PharmaceuticalsANIP

——

Eton Pharmaceuticals, Inc.ETON

——

TRV

Trevi Therapeutics, Inc.TRVI

——

MannkindMNKD

——

Acadia PharmaceuticalsACAD

——

Other financials

Income statement

See full

Revenue-—

Operating income-$39.0M-37.1%

Net income-$37.3M-40.0%

EPS (diluted)-$0.15-25.0%

Balance sheet

See full

Cash & equivalents$38.8M+98.4%

Total debt$30.1M+1.8%

Total equity$176.0M+19.1%

Total assets$221.6M+17.1%

Cash flow

See full

Operating cash flow-$33.0M-21.5%

CapEx$54.0K+1,700%

Free cash flow-$33.1M-21.7%

Valuation

See full

Market cap$1.19B+236%

Enterprise value$1.19B+224%

P/S4,648.7×—

Profitability

See full

Operating margin-19,183.3%—

Net margin-19,305.1%—

FCF margin-15,518.7%—

Returns & leverage

See full

Return on equity-80%+4.7pp

Debt / equity0.2×0.0×

Current ratio13.5×-1.4×

Where this comes from

Reported directly by Savara in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Savara’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Savara's other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Savara's other commercial liabilities?: Savara (SVRA) reported other commercial liabilities of $11.04M in Q1 2026.
How has Savara's other commercial liabilities changed year-over-year?: Savara's other commercial liabilities increased by 74.2% year-over-year, from $6.34M to $11.04M.
What is the long-term trend for Savara's other commercial liabilities?: Over 5 years (2020 to 2025), Savara's other commercial liabilities has grown at a 21.3% compound annual growth rate (CAGR), from $5.58M to $14.64M.